	Correlation of TP53 Mutations With p53 Expression and Ki-67 Index in Pulmonary Large Cell Neuroendocrine Carcinomas. APMIS Stampe M, Smidt J, Melchior L, Grauslund M, Federspiel B, Santoni-Rugiu E, Jensen THL. PMID: 41912255 [PubMed - indexed for MEDLINE]
	Bridging the gap between tumor evolution and clonality diagnostics in multiple lung carcinomas. Semin Cancer Biol Janssen J, Allgäuer M, Ylstra B, Draijer S, Kim Y, Budczies J, Kazdal D, Stenzinger A, Kirchner M, Radonic T. PMID: 41912125 [PubMed - as supplied by publisher]
	Updates on the Perioperative Management of Resectable Non-Small Cell Lung Cancer. J Natl Compr Canc Netw Frumm SM, Florez N, Lee JM, Rotow JK, Chaft JE. PMID: 41911908 [PubMed - as supplied by publisher]
	HSR26-260: Comparative Efficacy and Safety of Second-Line Therapies in Relapsed Small-Cell Lung Cancer: A Systematic Review and Pooled Analysis. J Natl Compr Canc Netw Tangella AV. PMID: 41911810 [PubMed - in process]
	CLO26-102: Progression-Free Survival of Pembrolizumab Monotherapy Versus Combination Therapy With Chemotherapy as First-Line Treatment in Advanced or Metastatic Non-Small-Cell Lung Cancer Without EGFR/ALK Mutations: A Systematic Review and Robust Meta-Analysis. J Natl Compr Canc Netw Yang W, Oh Y. PMID: 41911789 [PubMed - in process]
	CLO26-107: A Meta-Analysis and Network Meta-Analysis for Overall Survival of Pembrolizumab Monotherapy Versus Combined With Chemotherapy as First-Line Therapy in No EGFR/ALK-Mutation Advanced or Metastatic Non-Small-Cell Lung Cancer. J Natl Compr Canc Netw Yang W, Oh Y. PMID: 41911769 [PubMed - in process]
	Clinicogenomic Characteristics and Treatment Outcomes of Patients With Advanced ALK-Rearranged Squamous and Adenosquamous Non-Small Cell Lung Cancers. JCO Precis Oncol Miao EA, Yeap B, Daher S, Lomibao M, Sun F, Keogh R, Lambden J, Reyes A, Peterson JL, Liang J, Liu A, Do A, Lee C, Hsu M, Evangelist M, Reuss J, Gadgeel SM, Lee M, Patil T, Lam V, Neal JW, Drilon A, Lin JJ. PMID: 41911514 [PubMed - indexed for MEDLINE]
	The Digital Information Environment of Lung Cancer and Lung Cancer Screening: Protocol for a Cross-Platform Social Media Content Analysis. JMIR Res Protoc Carter-Bawa L, Vielma AG, Nealy G, Vemuganti D, Patel N. PMID: 41911368 [PubMed - indexed for MEDLINE]
	Use, Utility, and User Experience of Cloud-Based Medical Imaging in Pulmonary Nodule Care in China: Mixed Methods Study. J Med Internet Res Chen Z, Wu J, Chen Y, Zhuang W, Huang J, Zhong W, Li Z, Xie S, Liu C, Lu G, Qiao G. PMID: 41911365 [PubMed - indexed for MEDLINE]
	New Schiff Base Derivative Triazines: Their Synthesis, Molecular Docking Studies, and Anticancer Activities in Human Lung Cancer Cells. Chem Biol Drug Des , Mesci S, K, Yazgan B, Özdemir TT, Y. PMID: 41910944 [PubMed - indexed for MEDLINE]
	Early changes in pulmonary function after stereotactic body radiotherapy for lung oligometastases. J Cancer Res Ther Aksoy RA, Koca T, Ç, Dirol H, Korcum AF. PMID: 41910296 [PubMed - indexed for MEDLINE]
	A plain language summary of the updated results from the PHAROS study: the combination of encorafenib plus binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer. Future Oncol Johnson ML, Smit EF, Felip E, Ramalingam SS, Ahn MJ, Tsao A, Johnson BE, Offin M, Hussein M, Dagogo-Jack I, Goldman JW, Clarke JM, Negrao MV, Sanborn RE, Morgensztern D, Usari T, Wilner K, Alejandro L, Rifi N, Zhang X, Riely GJ. PMID: 41910021 [PubMed - as supplied by publisher]
	Gut microbiome and lung cancer: mechanisms, interactions, and dietary interventions. Gut Microbes Rep Chakraborty J, Lanchenba Singh N, Kumar Das B. PMID: 41909905 [PubMed]
	Diagnostic value of metagenomic next-generation sequencing in patients with febrile lung cancer with negative conventional microbiological tests and without neutropenia. Front Cell Infect Microbiol Wang C, Min M, Dai Z, Wang G, Wang Y, Hu T, Ma Y, Zhang S, Wu C, Zhou R. PMID: 41909845 [PubMed - indexed for MEDLINE]
	Clinical Outcomes of Osimertinib Combined with Platinum-Based Chemotherapy in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Study. Pharmgenomics Pers Med Han R, Yu X. PMID: 41908738 [PubMed]
	Recommendations for contouring of gross tumour volume for locally advanced lung cancer using magnetic resonance imaging. Phys Imaging Radiat Oncol Shiarli AM, Dubec MJ, Ahmed M, Asmussen JT, Bainbridge H, Belderbos JS, Brown S, Bussink J, Cobben D, Geurts BHJ, Hope A, Kavanagh J, Koh DM, Lalezari F, Louie AV, Merckel LG, Hoesein FAM, O'Connor JPB, Perez-Johnston R, Reeve TJ, Rimner A, van Rossum PSN, Schinagl DAX, Schytte T, Stevens C, Tan A, Tijssen RHN, Tunariu N, Herk MV, Verhoeff JJC, Wetscherek A, Wittenberg R, Woolf D, Faivre-Finn C, McDonald F. PMID: 41908729 [PubMed]
	Artificial Intelligence Assisted (18)F-FDG PET Radiomics in Classifying Histological Subtypes of Lung Cancer: Systematic Review and Meta-analysis. Nucl Med Mol Imaging Dwivedi P, Barage S, Jha A, Agrawal A, Singh R, Choudhury S, Rangarajan V. PMID: 41908706 [PubMed]
	Anticancer Activity and Molecular Docking Studies of Selected Benzoxazole Derivatives as Apoptosis Inducers in Non-Small Cell Lung Cancer. J Clin Pract Res Baba B, Köprü ÇZ, Yildiz I, Yardimci E, Akbay A. PMID: 41908352 [PubMed]
	Osimertinib for Patients With EGFR-Mutated Non-Small Cell Lung Cancer: Current Evidence. Clin Med Insights Oncol Tang X, Chen Y, Zhu Y, Liu Y, Li W, Wang W, Wang Z. PMID: 41907704 [PubMed]
	Molecular typing of stage IB non-small-cell lung cancer for precision medicine. Front Oncol Li X, Wan Z, Wen M, Zhu J, Wei K, Ji X, Zhang J, Li G, Lei J, Feng Y, Xiong Y, Zhou Y, Xin S. PMID: 41907612 [PubMed]

Articles 1 - 20 / 157561

Page 1 of 7879



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy